je.st
news
Tag: in
The 10 Best States to Retire in 2016
2016-01-29 09:00:00| National Real Estate Investor
Which states are the most attractive to retirees, based on affordability, quality of life and health care options? read more
Amazon.com sales jump 22% to USD 36 bln in Q4
2016-01-29 08:02:00| Telecompaper Headlines
(Telecompaper) Amazon.com saw its net sales for its fourth quarter to 31 December increase 22 percent year-on-year to USD 35.7 billion. Net income more than doubled to USD 482 million in the fourth quarter, or USD 1.00 per diluted share, compared with net income of USD 214 million, or USD 0.45 per diluted share, in fourth quarter 2014. The company expects net sales in Q1 2016 to be between USD 26.5 billion and USD 29.0 billion, or to grow between 17 percent and 28 percent compared with first quarter 2015.
Marco Rubio Was A Big Proponent Of Cap And Trade In Florida
2016-01-29 04:32:00| Climate Ark Climate Change & Global Warming Newsfeed
Buzzfeed: When asked about addressing climate change during Wednesday nights debate, Marco Rubio said the policies put forward by liberals would have a detrimental effect on the U.S. economy. However, while serving as the speaker of the Florida House of Representatives, Rubio repeatedly espoused the potential benefits of cap and trade programs and presided over the passage of a bill allowing the state to set rules for such a system and encouraging a transition away from electricity produced by burning fossil...
The founder of a $750 million startup says the most successful entrepreneurs have 3 things in common
2016-01-29 02:48:39| Apparel - Topix.net
Instagram cofounder and CEO Kevin Systrom talks with Harry's cofounder and co-CEO Jeff Raider for Harry's H'University series. Harry's cofounders and co-CEOs Andy Katz-Mayfield and Jeff Raider have not only created a men's razor startup that acquired one million customers and reached a valuation of $750 million since launching in 2013, but they've developed a network of highly successful entrepreneurs to learn from.
Tags: in
things
common
million
Merck Receives FDA Approval of ZEPATIER (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
2016-01-29 00:59:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1 or GT4 infection, with or without ribavirin (RBV), following priority review by the FDA. Language: English Contact: MerckMedia:Doris Li, 908-246-5701Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
following
review
treatment
Sites : [570] [571] [572] [573] [574] [575] [576] [577] [578] [579] [580] [581] [582] [583] [584] [585] [586] [587] [588] [589] next »